JP (Jiapeng) received his Ph.D. in Pharmaceutical Sciences from the University of Cincinnati. His doctoral research focused on post-stroke neuronal repair and functional recovery by utilizing adult neurogenesis as an endogenous source. As a Staff Scientist in the Brain Targeting Program at the Wyss, JP’s work focuses on the discovery and validation of novel antibody shuttles that efficiently deliver therapeutic payloads across the blood-brain barrier (BBB), and the development of human in vitro models for Alzheimer’s disease.